Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – Outcomes in patients with acute MI undergoing percutaneous coronary intervention are better with increasing levels of LDL cholesterol, a Korean group reports. However,…
NEW YORK (Reuters Health) – Results of a small study indicate that transdermal testosterone improves functional capacity and other parameters in elderly women with chronic heart failure. Writing…
NEW YORK (Reuters Health) – Compared with unfractionated heparin, bivalirudin used for anticoagulation in unselected patients undergoing percutaneous coronary intervention is associated with less bleeding after 1 month…
NEW YORK (Reuters Health) – The diagnostic accuracy of rotational coronary angiography is as good as that of conventional angiography, but it significantly reduces the amount of radiation…
NEW YORK (Reuters Health) – Determining the low-density lipoprotein particle (LDL-p) concentration in women with HIV doesn’t seem to be worthwhile, as doing so adds little information beyond…
NEW YORK (Reuters Health) – In recipients of drug-eluting coronary stents who undergo a major noncardiac surgical procedure some months later, the risk of adverse outcomes is less…
NEW YORK (Reuters Health) – Left ventricular thrombus is still quite a frequent finding in patients with an anterior wall MI who have been treated by percutaneous coronary…
NEW YORK (Reuters Health) – Patients with NYHA class I or II heart failure benefit from spironolactone therapy as well as those with class III or IV HF,…
NEW YORK (Reuters Health) – Delivery of abciximab directly to the intracoronary thrombus in patients with acute coronary syndromes is more effective than intracoronary bolus infusion in reducing…
NEW YORK (Reuters Health) – The concern about proton pump inhibitors (PPIs) possibly interfering with the efficacy of clopidogrel may be misdirected, according to a new report. It…
